SB 1250: Cancer Clinical Trials
GENERAL BILL by Simmons
Cancer Clinical Trials; Requiring cancer clinical trial programs to inform potential participants of the specified reimbursements for ancillary costs and travel expenses which may be available to them if they participate in a cancer clinical trial; authorizing corporations, individuals, public and private foundations, health care providers, and other stakeholders to offer financial assistance to support approved reimbursements of ancillary costs and travel expenses for participants in a cancer clinical trial, etc.
Effective Date: 7/1/2017
Last Action: 5/5/2017 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Last Action: 5/5/2017 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Senate Committee References:
- Health Policy (HP)
- Appropriations Subcommittee on Health and Human Services (AHS)
- Appropriations (AP)
- Rules (RC)
-
Bill History
Date Chamber Action 2/24/2017 Senate • Filed
3/6/2017 Senate • Referred to Health Policy; Appropriations Subcommittee on Health and Human Services; Appropriations; Rules -SJ 131
3/7/2017 Senate • Introduced -SJ 131
5/5/2017 Senate • Indefinitely postponed and withdrawn from consideration
• Died in Health Policy
-
SB 1250, Original Filed Version (Current Bill Version) Posted 2/24/2017 at 4:22 PM
Bill Text: Web Page | PDF Analyses: None Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 385.2021 Page 1 (pdf)